minal

Right Now

Transfer Membrane Market Size Worth $554.4 Million By 2030

The global transfer membrane market size is estimated to reach USD 554.4 million by 2030, registering a CAGR of 4.53% from 2023 to 2030, according to a new report by Grand View Research, Inc. Transfer membranes are used for transferring nucleic acids or proteins in blotting techniques such as Western blotting, Southern blotting, Northern blotting, etc. The growing applications of these techniques in gene mapping, DNA fingerprinting, proteomic analysis, etc. are increasing the utility of transfer membranes in the life sciences research industry globally.

Moreover, the demand for blotting techniques is growing substantially for the early detection of target diseases and causative agents. These techniques offer high sensitivity and specificity which boosts the adoption of transfer membranes for several diagnostics purposes. Hence, the growing demand for blotting membranes for detecting HIV infection, bovine spongiform encephalopathy, feline immunodeficiency virus infection, HBV infection, etc. is expected to boost the market growth. Similarly, the rising focus and rapid advancements in the development of novel therapies for the treatment of such disorders is anticipated to drive the market growth.

Furthermore, techniques such as Southern blotting are used for the identification of specific DNA sequences in a DNA sample and hence have applications in the recombinant DNA technology where they are used for the isolation of specific DNA fragments. It is also used in academic research studies aimed at identifying mutations and gene rearrangements to better understand neonatal and genetic diseases. Such widespread applications of the technique have led to an established market presence of transfer membranes which can positively affect the market growth in the near future.

The COVID-19 outbreak positively affected the transfer membranes market in 2020 and 2021 as these membranes were used in the clinical investigation and diagnostic applications for the disease. For instance, Western blots were used as a confirmatory test for the positive or borderline-positive results from other screening tests. Similarly, Northern blotting techniques were used in identification of various sub-genomes of the SARS-CoV-2 virus. In addition, by May 2021, the U.S. and Germany had invested over USD 2 billion and USD 1.5 billion, respectively, in COVID-19 vaccine research and development activities which boosted the growth of life science research tools such as transfer membranes in 2021.

Transfer Membrane Market Report Highlights

PVDF membranes segment held the largest share of 39.57% in 2022, owing to its benefits over the other membranes including nitrocellulose, and nylon, such as high protein binding capacity, high durability, and higher chemical resistance, among others
By transfer method, the dry electro blotting (dry transfer) segment held the largest market share of 37.54% in 2022, owing to the less transfer time required for this method coupled with the lower cost and less cleanup required
By application, the western blotting segment accounted for the largest share of 55.95% in the transfer membrane market in 2022. This can be attributed to the widespread diagnostic applications of the technique
By end-user, the biopharmaceutical & pharmaceutical companies segment held the largest share of 62.80% in 2022. The high share of the segment is attributable to the growing investment in research activities undertaken in such facilities
North America held the largest market share of 37.91% in 2022. This can be attributed to the presence of major global players in the market, and growing investments from the public and private organizations for proteomic and life science research in the region

Transfer Membrane Market Segmentation

Grand View Research has segmented the global transfer membrane market based on the product, transfer method, application, end-user, and region:

Transfer Membrane Product Outlook (Revenue, USD Million, 2018 - 2030)